BPG is committed to discovery and dissemination of knowledge
Review
Copyright ©The Author(s) 2025.
World J Hepatol. Nov 27, 2025; 17(11): 113756
Published online Nov 27, 2025. doi: 10.4254/wjh.v17.i11.113756
Table 1 The function of short-chain fatty acids in immune regulation during metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis
SCFAs
Immune cells
Function
Ref.
AcetateMacrophagesA lower dose (0.1 mmol/L) of sodium acetate promotes macrophage inflammation (RAE264.7 cells and Kupffer cells) by promoting the phosphorylation of NF-κB p65 and c-Jun (transcription factor Jun), whereas a higher dose (2 mmol/L) of sodium acetate showed the opposite effect[39]
AcetateMacrophagesSodium acetate-loaded liposomes effectively inhibited lipopolysaccharide-activated Kupffer cell proinflammation[41]
AcetateCD8+ T cellsAcetate can promote the conversion of liver-resident CXCR6+ CD8+ T cells to cytotoxic, auto-aggressive CD8+ T cells in MASH liver, promoting liver damage[42]
ButyrateMacrophagesSodium butyrate can inhibit hepatic monocyte-derived macrophage infiltration and promote the apoptosis of proinflammatory M1 macrophages while activating the M2-like macrophages in MASH livers, thereby leading to the healing process[44]
ButyrateNK cellsGut bacteria-derived butyrate can promote the maturation of mouse and human liver-resident NK cells by increasing the expression levels of IFN-γ and CD107a, through IL-18 production in hepatocytes and Kupffer cells[45]
ButyrateCD8+ T cellsGut microbiota-induced butyrate is responsible for the successful transition from activated CD8+ T cells to memory CD8+ T cells and maintains the survival of memory precursors of CD8+ T cells[47]
ButyrateCD4+ T cellsSodium butyrate can promote CD4+ T cell differentiation towards Th2, Th22, and Tregs[54]
PropionateMacrophagesPropionic acid can suppress M1 macrophage polarization by inhibiting MAPK signaling pathway[55]
Propionateγδ T cellsPropanoic acid derived from gut microbiota can suppress liver inflammation by decreasing the IL-17-producing γδ T cells[56]
PropionateT helper cellsPropionate alone or in combination with acetate reduced the numbers of Th1 and Th17 cells and increased the number of Tregs in the spleens and mesenteric lymph nodes of HFD-fed mice[64]
Table 2 Clinical trials in the treatment of metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis
Clinical trials
Phase
Disease
Treatment
Measurements
NCT05654805N/AMASLDOat-fiber supplementationFermentation to short-chain fatty acids (SCFAs)
NCT05523024N/AMASLDDietary supplementation of probiotics; Dietary supplementation of Berberine; Dietary supplementation of Probiotics and BerberineThe concentrations of SCFAs in stool
NCT05402449N/AMASLDDietary supplementation of probiotics, including Lactobacillus reuteri GMNL-263 (heat-killed) and GMNL-89 (alive), and Lactobacillus rhamnosus GMNL-74 (alive)Concentrations of SCFAs in blood
NCT04594954N/AMASLDFecal microbiota transplantation Production of SCFAs
NCT04415632N/AMASLDLow glycemic index diet; High glycemic index dietPlasma concentrations of SCFAs
NCT04117802N/AMASLDMaple syrupChange of fecal SCFAs
NCT01856465N/AMASLDBariatric surgeryChange of fecal SCFAs
NCT054635752MASLDKetohexokinase inhibitionChange of fecal SCFAs, including acetate, propionate, and butyrate
NCT058210102MASHLyophilized fecal microbiota transplantation capsules Anaerobutyricum soehngenii; Pasteurized Akkermansia muciniphila; Bifidobacterium animalis subsp. Lactis; Fructo-oligosaccharidesConcentrations of SCFAs in blood (i.e., acetate, butyrate, and propionate)
NCT056479154Obesity
MASLD
Berberine plus lifestyle interventionChange of SCFAs
NCT044650324MASLDGut microbiome transplantationProduction of SCFAs